Lipid A and related compounds. XXXIII. synthesis and structure-activity relationships of N-acylated L-serine or L-threonine-containing D-glucosamine derivatives as mimics of lipid A disaccharide

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 6, 1997, Pages 1089-1093

  Miyajima, Keisuke ^a   Gomi, Noriaki ^a   Ikeda, Kiyoshi ^a   Achiwa, Kazuo ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Lipid A analog; Mitogenic activity; N acylated L threonine; Structure activity relationship

Indexed keywords

GLUCOSAMINE DERIVATIVE; LIPID A; LIPID A DERIVATIVE; SERINE DERIVATIVE; THREONINE;

ACYLATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; IMMUNOMODULATION; MITOGENESIS; STRUCTURE ACTIVITY RELATION;

EID: 0030748862     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.1089     Document Type: Article

References (21)

1. Lipid A and Related Compounds. XXXIII. Part XXXII: Reference 6b.
2. a) Galanos C., Lüderitz O., Rietschel E. T., Westphal O., Int. Rev. Biochem., 14, 239-335 (1977);
3. b) Lüderitz O., Galanos C., Lehmann V., Mayer H., Rietschel E. T., Weckesser J., Naturwissenschaften, 65, 578-585 (1978).
4. Shiba T., Kusumoto S., J. Synthetic Org. Chem., 42, 507-513 (1986).
5. Suhara Y., Arakawa K., Ikeda K., Achiwa K., Chem. Pharm. Bull., 42, 2526-2531 (1994).
6. a) Pedron T., Girard R., Eustache J., Bulusu M. A. R. C., Macher I., Radzyner-Vyplel H., Stütz P. L., Chaby R., Int. Immunol., 4, 533-540 (1992);
7. b) Bulusu M. A. R. C., Waldstätten P., Hildebrandt J., Schütze E., Schulz G., J. Med. Chem., 35, 3463-3469 (1992);
8. c) Bulusu M. A. R. C., Waldstätten P., Tetrahedron Lett., 30, 1859-1862 (1992);
9. d) Kawai Y., Akagawa K., Infect. Immun., 57, 2086-2091 (1989);
10. e) Brade L., Bessler W. G., Brade H., ibid., 56, 1382-1384 (1988);
11. f) Eustache J., Grob A., Retscher H., Carbohydr. Res., 251, 251-267 (1994).
12. a) Miyajima K., Ikeda K., Achiwa K., Chem. Pharm. Bull., 44, 2268-2273 (1996);
13. b) Miyajima K., Achiwa K., ibid., 45, 312-320 (1997);
14. c) Shimizu T., Sugiyama K., Iwamoto Y., Yanagihara T., Asahara T., Ikeda K., Achiwa K., Int. J. Immunopharmac., 16, 659-665 (1994);
15. d) Shimizu T., Iida K., Iwamoto Y., Yanagihara Y., Ryoyama K., Asahara T., Ikeda K., Achiwa K., ibid., 17, 425-431 (1995).
16. Shimizu T., Akiyama S., Masuzawa T., Yanagihara Y., Nakamoto S., Takahashi T., Ikeda K., Achiwa K., Chem. Pharm. Bull., 33, 4621-4624 (1985).
17. Fukase F., Hasuoka A., Kusumoto S., Tetrahedron Lett., 34, 2187-2222 (1993).
18. a) Schultz M., Kunz H., Tetrahedron: Asymmetry, 4, 1205-1220 (1993);
19. b) Nagao Y., Nekado T., Ikeda K., Achiwa K., Chem. Pharm. Bull., 43, 1536-1542 (1995).
20. Bock K., Pedersen C., J. Chem. Soc., Perkin Trans. 2, 1974, 293-297.
21. Shimizu T., Akiyama S., Masuzawa T., Yanagihara Y., Nakamoto S., Achiwa K., Infect Immun., 55, 2287-2289 (1987).